NCT02057380 2024-11-20
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Astellas Pharma Inc
Phase 2 Completed
Astellas Pharma Inc
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute